Literature DB >> 30214480

Insights into pregnancy associated and atypical hemolytic uremic syndrome.

Sophie Grand'Maison1,2, Stephen Lapinsky3.   

Abstract

Entities:  

Year:  2018        PMID: 30214480      PMCID: PMC6134353          DOI: 10.1177/1753495X18780099

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


× No keyword cloud information.
  8 in total

Review 1.  Pregnancy-related thrombotic microangiopathies: Clues from complement biology.

Authors:  Fadi Fakhouri
Journal:  Transfus Apher Sci       Date:  2016-04-25       Impact factor: 1.764

2.  The long-term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy.

Authors:  J S Dashe; S M Ramin; F G Cunningham
Journal:  Obstet Gynecol       Date:  1998-05       Impact factor: 7.661

3.  A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.

Authors:  Ana Huerta; Emilia Arjona; Jose Portoles; Paula Lopez-Sanchez; Cristina Rabasco; Mario Espinosa; Teresa Cavero; Miquel Blasco; Mercedes Cao; Joaquin Manrique; Virginia Cabello-Chavez; Marta Suñer; Manuel Heras; Xavier Fulladosa; Lara Belmar; Amparo Sempere; Carmen Peralta; Lorena Castillo; Alvaro Arnau; Manuel Praga; Santiago Rodriguez de Cordoba
Journal:  Kidney Int       Date:  2017-09-12       Impact factor: 10.612

4.  Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome.

Authors:  Martina Gaggl; Christof Aigner; Dorottya Csuka; Ágnes Szilágyi; Zoltán Prohászka; Renate Kain; Natalja Haninger; Maarten Knechtelsdorfer; Raute Sunder-Plassmann; Gere Sunder-Plassmann; Alice Schmidt
Journal:  J Am Soc Nephrol       Date:  2017-12-27       Impact factor: 10.121

Review 5.  Syndromes of Thrombotic Microangiopathy.

Authors:  Joseph J Shatzel; Jason A Taylor
Journal:  Med Clin North Am       Date:  2016-12-27       Impact factor: 5.456

6.  Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

Authors:  C M Legendre; C Licht; P Muus; L A Greenbaum; S Babu; C Bedrosian; C Bingham; D J Cohen; Y Delmas; K Douglas; F Eitner; T Feldkamp; D Fouque; R R Furman; O Gaber; M Herthelius; M Hourmant; D Karpman; Y Lebranchu; C Mariat; J Menne; B Moulin; J Nürnberger; M Ogawa; G Remuzzi; T Richard; R Sberro-Soussan; B Severino; N S Sheerin; A Trivelli; L B Zimmerhackl; T Goodship; C Loirat
Journal:  N Engl J Med       Date:  2013-06-06       Impact factor: 91.245

7.  Hemolytic Uremic Syndrome in Pregnancy and Postpartum.

Authors:  Alexandra Bruel; David Kavanagh; Marina Noris; Yahsou Delmas; Edwin K S Wong; Elena Bresin; François Provôt; Vicky Brocklebank; Caterina Mele; Giuseppe Remuzzi; Chantal Loirat; Véronique Frémeaux-Bacchi; Fadi Fakhouri
Journal:  Clin J Am Soc Nephrol       Date:  2017-06-08       Impact factor: 8.237

Review 8.  HUS and atypical HUS.

Authors:  T Sakari Jokiranta
Journal:  Blood       Date:  2017-04-17       Impact factor: 25.476

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.